SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $542,000 | +24.3% | 4,901 | -12.7% | 0.05% | +19.0% |
| Q2 2021 | $436,000 | -44.7% | 5,612 | -47.0% | 0.04% | -25.0% |
| Q1 2021 | $789,000 | +34.4% | 10,586 | +207.4% | 0.06% | -11.1% |
| Q4 2020 | $587,000 | +34.3% | 3,444 | +26.4% | 0.06% | +26.0% |
| Q2 2020 | $437,000 | -9.0% | 2,725 | -32.3% | 0.05% | +85.2% |
| Q1 2019 | $480,000 | -60.9% | 4,027 | -64.2% | 0.03% | -59.1% |
| Q4 2018 | $1,227,000 | +57.9% | 11,240 | +91.1% | 0.07% | +94.1% |
| Q2 2018 | $777,000 | +18.4% | 5,881 | -33.6% | 0.03% | -2.9% |
| Q1 2018 | $656,000 | – | 8,857 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |